Verona Pharma American Depositary Share research and development expenses for the twelve months ending September 30, 2024 were $0.041B, a 104.83% increase year-over-year.
Verona Pharma American Depositary Share annual research and development expenses for 2023 were $0.017B, a 65.07% decline from 2022.
Verona Pharma American Depositary Share annual research and development expenses for 2022 were $0.049B, a 37.94% decline from 2021.
Verona Pharma American Depositary Share annual research and development expenses for 2021 were $0.079B, a 78.42% increase from 2020.
Verona Pharma American Depositary Share Research and Development Expenses 2017-2024 | VRNA